Science

Distinct molecular and clinical features of KRAS G12 mutations in Pancreatic Cancer

Pancreatic cancer/X

Jan 21, 2025, 14:15

Distinct molecular and clinical features of KRAS G12 mutations in Pancreatic Cancer

Jash Datta, Associate Professor at University of Miami’s Miller School of Medicine, posted on X about recent paper by Bach Ardalan et al., titled “Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma” published on AACR Journals.

Authors: Bach Ardalan, Aaron Ciner, Yasmine Baca, Andrew Hinton, Sourat Darabi, Anup Kasi, Emil Lou, Jose Ignacio Azqueta, Joanne Xiu, Jashodeep Datta, Anthony F. Shields, Andrew Aguirre, Harshabad Singh, Rachna T. Shroff, Michael J. Pishvaian, Sanjay Goel.

“A success for our GI Oncology Site Disease Group at Sylvester Comprehensive Cancer Center, with Bach Ardalan leading this at Clinical Cancer Research on distinct molecular and clinical features of KRAS G12 mutations, especially KRAS G12R, in Pancreatic Cancer!

Builds on ongoing work with Caris Life Sciences.”

AACR Aaron Ciner Andrew Aguirre Andrew Hinton Anthony F Shields Anup Kasi Bach Ardalan cancer Caris Life Sciences Clinical Cancer Research Emil Lou Harshabad Singh Jashodeep Datta Joanne Xiu Jose Ignacio Azqueta KRAS G12R Michael J Pishvaian OncoDaily Oncology Pancreatic Cancer Rachna T. Shroff Sanjay Goel Sourat Darabi sylvester Cancer Center Sylvester Comprehensive Cancer Center Yasmine Baca

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results